Cargando…

Methodological challenges surrounding QALY estimation for paediatric economic evaluation

Cost-utility analysis remains the preferred form of economic evaluation for health technology assessment, pricing and reimbursement authorities in several countries. The results of cost-utility analyses are commonly expressed in terms of incremental cost per quality-adjusted life year (QALY) gained...

Descripción completa

Detalles Bibliográficos
Autor principal:	Petrou, Stavros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896090/ https://www.ncbi.nlm.nih.gov/pubmed/35241102 http://dx.doi.org/10.1186/s12962-022-00345-4

Ejemplares similares

The PROMIS of QALYs
por: Hanmer, Janel, et al.
Publicado: (2015)

Abandoning Eugenics and the QALY
por: Langley, Paul C
Publicado: (2021)

The Great I-QALY Disaster
por: Langley, Paul C.
Publicado: (2020)

ICER, ISPOR AND QALYs: Tales of Imaginary Worlds
por: Langley, Paul C
Publicado: (2019)

Problems and solutions in calculating quality-adjusted life years (QALYs)
por: Prieto, Luis, et al.
Publicado: (2003)

Using QALYs in telehealth evaluations: a systematic review of methodology and transparency
por: Bergmo, Trine S
Publicado: (2014)

After The QALY: Training for a New Start Paradigm in Health Technology Assessment
por: Langley, Paul C, et al.
Publicado: (2023)

Estimation of Lifetime QALYs Based on Lifestyle Behaviors
por: Noto, Shinichi, et al.
Publicado: (2021)

The Impossible QALY and the Denial of Fundamental Measurement: Rejecting the University of Washington Value Assessment of Targeted Immune Modulators (TIMS) in Ulcerative Colitis for the Institute for Clinical and Economic Review (ICER)
por: Langley, Paul C
Publicado: (2020)

Measurement, modeling and QALYs
por: Langley, Paul C., et al.
Publicado: (2020)

A QALY loss is a QALY loss is a QALY loss: a note on independence of loss aversion from health states
por: Lipman, Stefan A., et al.
Publicado: (2018)

QALYs: The Math Doesn’t Work
por: Sawhney, Tia G., et al.
Publicado: (2023)

Estimating a constant WTP for a QALY—a mission impossible?
por: Sund, Björn, et al.
Publicado: (2017)

The cost-per-QALY threshold in England: Identifying structural uncertainty in the estimates
por: Zamora, Bernarda, et al.
Publicado: (2023)

A methodological framework for assessing agreement between cost-effectiveness outcomes estimated using alternative sources of data on treatment costs and effects for trial-based economic evaluations
por: Achana, Felix, et al.
Publicado: (2017)

Challenges and Solutions Surrounding Environmental Enrichment for Dogs and Cats in a Scientific Environment
por: Desforges, Emma
Publicado: (2021)

Survivorship and (QALY)ty: In Pursuit of a Mirage?
por: Vijayaragavan, Bharath Kumar Tirupakuzhi, et al.
Publicado: (2019)

Stroke survivors’ long-term QALY-weights in relation to their spouses’ QALY-weights and informal support: a cross-sectional study
por: Persson, Josefine, et al.
Publicado: (2017)

Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance
por: Holmes, Emily A. F., et al.
Publicado: (2019)

Ethical Issues Surrounding Newborn Screening
por: Howell, R. Rodney
Publicado: (2021)

Health economic evaluation of gene replacement therapies: methodological issues and recommendations
por: Aballéa, Samuel, et al.
Publicado: (2020)

Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010
por: Wisløff, Torbjørn, et al.
Publicado: (2014)

Aspirin and clopidogrel resistance: methodological challenges and opportunities
por: Gasparyan, Armen Yuri
Publicado: (2010)

Economic Evaluation in Stratified Medicine: Methodological Issues and Challenges
por: Fugel, Hans-Joerg, et al.
Publicado: (2016)

Understanding the agreements and controversies surrounding childhood psychopharmacology
por: Parens, Erik, et al.
Publicado: (2008)

Biomedical and Market Issues Surrounding the Advent of Biosimilars
por: Cline, Abigail, et al.
Publicado: (2016)

Commentary: A phase in the haze surrounding the maze
por: Harken, Alden H.
Publicado: (2020)

Impact of work-related cancers in Taiwan—Estimation with QALY (quality-adjusted life year) and healthcare costs
por: Lee, Lukas Jyuhn-Hsiarn, et al.
Publicado: (2016)

Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
por: Petrou, Stavros, et al.
Publicado: (2011)

Commentary: Postoperative pericardial effusion: Surrounded by a conundrum
por: Ozturk, Mahmut, et al.
Publicado: (2022)

The controversy surrounding OxyContin abuse: issues and solutions
por: Jayawant, Sujata S, et al.
Publicado: (2005)

Payment in challenge studies from an economics perspective
por: Ambuehl, Sandro, et al.
Publicado: (2020)

Economic Evaluation of Environmental Interventions: Reflections on Methodological Challenges and Developments
por: Bojke, Laura, et al.
Publicado: (2018)

Methodological Challenges in the Economic Evaluation of Occupational Health and Safety Programmes
por: Steel, Jonas, et al.
Publicado: (2018)

Systematic review of economic evaluations of varicella vaccination programmes
por: Anderson, Robert, et al.
Publicado: (2023)

The social value of a QALY: raising the bar or barring the raise?
por: Donaldson, Cam, et al.
Publicado: (2011)

Setting Dead at Zero: Applying Scale Properties to the QALY Model
por: Roudijk, Bram, et al.
Publicado: (2018)

Dimensions Used in Instruments for QALY Calculation: A Systematic Review
por: Touré, Moustapha, et al.
Publicado: (2021)

Modelling Spillover Effects on Informal Carers: The Carer QALY Trap
por: Mott, David J., et al.
Publicado: (2023)

Estimation of the Lifetime Quality-Adjusted Life Years (QALYs) Lost Due to Syphilis Acquired in the United States in 2018
por: Lee, Kyueun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i1dk4tiqihk5jbc6mukuhtdbd5